Furthermore, the Bulk Tumor, Proliferating, and CD44 Immune CNs, which particularly compose the TLSs evident within 2 cores (1 patient) of the 5-year survival cohort, are enriched albeit not significantly (Fig. 5e, Supplementary File 7). This evidence concerns the gene CD44 and neoplasm.